Total Payments
$1,377
2024 Payments
$203.74
Companies
12
Transactions
47
Medicare Patients
4,193
Medicare Billing
$593,253
Payment Breakdown by Category
Food & Beverage$1,377 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,377 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $468.35 | 21 | $0 (2024) |
| Abbott Laboratories | $448.73 | 6 | $0 (2018) |
| Merz Pharmaceuticals, LLC | $117.99 | 3 | $0 (2024) |
| Medtronic, Inc. | $101.88 | 2 | $0 (2022) |
| Allergan, Inc. | $81.67 | 5 | $0 (2022) |
| DePuy Synthes Sales Inc. | $36.39 | 3 | $0 (2018) |
| Ultragenyx Pharmaceutical Inc. | $30.41 | 2 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $28.02 | 1 | $0 (2023) |
| Averitas Pharma Inc. | $22.84 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $14.94 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.74 | 8 | ABBVIE INC. ($169.94) |
| 2023 | $397.16 | 17 | ABBVIE INC. ($298.41) |
| 2022 | $184.70 | 6 | Medtronic, Inc. ($101.88) |
| 2021 | $30.38 | 2 | Allergan, Inc. ($30.38) |
| 2020 | $12.32 | 1 | Ultragenyx Pharmaceutical Inc. ($12.32) |
| 2019 | $11.32 | 1 | Lilly USA, LLC ($11.32) |
| 2018 | $69.50 | 5 | DePuy Synthes Sales Inc. ($36.39) |
| 2017 | $468.01 | 7 | Abbott Laboratories ($430.56) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/25/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Musculoskeletal | ||||||
| 01/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $28.02 | General |
| Category: Neurology | ||||||
| 11/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/20/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $47.89 | General |
| Category: Musculoskeletal | ||||||
| 05/12/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/19/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/09/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/01/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,052 | 8,971 | $374,895 | $169,124 |
| 2022 | 12 | 1,207 | 1,801 | $288,400 | $153,879 |
| 2021 | 14 | 1,179 | 6,514 | $336,035 | $180,828 |
| 2020 | 10 | 755 | 1,081 | $158,465 | $89,422 |
Total Patients
4,193
Total Services
18,367
Medicare Billing
$593,253
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 356 | 790 | $82,950 | $51,814 | 62.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 7,300 | $109,500 | $36,320 | 33.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 182 | 186 | $50,220 | $26,331 | 52.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 142 | 224 | $45,920 | $17,014 | 37.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 111 | 112 | $29,120 | $11,406 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 71 | $12,425 | $6,730 | 54.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 45 | 45 | $15,075 | $5,590 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,210 | $3,331 | 53.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 33 | $4,950 | $3,259 | 65.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 29 | $4,640 | $1,772 | 38.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 17 | $3,400 | $1,616 | 47.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 23 | $2,990 | $1,414 | 47.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 19 | 29 | $3,915 | $1,376 | 35.2% |
| 97811 | Acupuncture, each additional 15 minutes | Office | 2023 | 11 | 28 | $1,820 | $673.12 | 37.0% |
| 97810 | Acupuncture, initial 15 minutes | Office | 2023 | 11 | 14 | $1,330 | $442.54 | 33.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 43 | $430.00 | $35.18 | 8.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 464 | 905 | $95,025 | $53,327 | 56.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 274 | 291 | $78,570 | $46,835 | 59.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 114 | 172 | $30,985 | $13,707 | 44.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 130 | $19,500 | $11,028 | 56.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 83 | 84 | $21,615 | $9,085 | 42.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 40 | 41 | $13,735 | $5,689 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 55 | $9,625 | $5,024 | 52.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 47 | 50 | $6,415 | $2,835 | 44.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 25 | $4,860 | $2,166 | 44.6% |
About Dr. David Gordon, MD
Dr. David Gordon, MD is a Physical Medicine & Rehabilitation healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558359018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gordon, MD has received a total of $1,377 in payments from pharmaceutical and medical device companies, with $203.74 received in 2024. These payments were reported across 47 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,377).
As a Medicare-enrolled provider, Gordon has provided services to 4,193 Medicare beneficiaries, totaling 18,367 services with total Medicare billing of $593,253. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Novi, MI
- Active Since 10/10/2005
- Last Updated 07/10/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1558359018
Products in Payments
- BOTOX (Biological) $508.39
- DRG leads (Device) $284.00
- Xeomin (Biological) $117.99
- DRG IPGs (Device) $86.36
- ACCURIAN (Device) $82.22
- SCS leads (Device) $60.20
- MONOVISC (Device) $36.39
- Trudhesa (Drug) $28.02
- BOTOX - SPASTICITY (Drug) $23.54
- QUTENZA (Drug) $22.84
- INTELLIS ADAPTIVESTIM (Device) $19.66
- Neuromodulation Dspsbls and Accs (Device) $18.17
- QULIPTA (Drug) $18.09
- Strensiq (Drug) $14.94
- General - Pain Management (Device) $14.59
- EMGALITY (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Novi
Dr. Eric Kovan, Do, DO
Physical Medicine & Rehabilitation — Payments: $12,057
Physical Medicine & Rehabilitation $12,057
Dr. Michael Haenick, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,866
Physical Medicine & Rehabilitation $4,866
Dr. Jenny Michaels, Md Mph, MD MPH
Physical Medicine & Rehabilitation — Payments: $3,511
Physical Medicine & Rehabilitation $3,511
Dr. Dorin Deitch, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,477
Physical Medicine & Rehabilitation $3,477
Dennis Bandemer, Do, DO
Physical Medicine & Rehabilitation — Payments: $3,158
Physical Medicine & Rehabilitation $3,158
M Jackson, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,217
Physical Medicine & Rehabilitation $2,217